Published July 17 & 24 (EPO); July 11 & 18 (WO)
Alteon Glycosylation WO 96/20958
Ramsey, N.J. antibodies
Monoclonal antibodies to advanced glycosylation end products; fordiagnosis and therapy.
Boehringer Ingelheim IL-2 receptor- WO 96/21732
Ingelheim, Germany associated peptide
Gene for interleukin-2 (IL-2) receptor-associated polypeptide,encoded protein.
Bio-Technology General Human WO 96/20724
Iselin, N.J. insulin production
Production of recombinant human insulin by folding of a proinsulinhybrid polypeptide.
Bristol-Myers Squibb Topoisomerase EPO 723 018
Princeton, N.J. poisons
Expression vectors with human topoisomerase I, for detectingtopoisomerase inhibitors.
California, Univ. of Connective tissue WO 96/21006
Los Angeles phosphoprotein
Gene for mammalian bone connective tissue phosphoprotein,encoded protein, antibodies to it.
California, Univ. of Borna disease WO 96/21020
Oakland, Calif. virus
Genes for Borna disease viral proteins, encoded proteins, vectors,cells, antibodies; for diagnosis and therapy.
Catalytic Antibodies Proteolytic WO 96/21009
San Francisco enzyme screen
Proteolytic enzyme screen using bacteriophage containing DNAlibraries that are transfected into detector cell lines.
Chiron Controlled WO 96/20947
Emeryville, Calif. polynucleotide mixtures
Methods for controlled synthesis of polynucleotide mixturesencoding peptide mixtures with desired target activity.
Chiron Viagene Gene delivery WO 96/20731,
Emeryville, Calif. devices 20732 & 21015
Non-traumatic administration of combination gene delivery devicesat multiple sites; for inducing immunity.
Chiron Viagene Bacteriophage- WO 96/21007
Emeryville, Calif. mediated gene therapy
Bacteriophage-mediated gene transfer systems targeted to receptorsin eukaryotic cells; for gene therapy.
Chiron Viagene High titer WO 96/21014
Emeryville, Calif. recombinant retroviruses
Production and administration of high titer recombinant retroviruseswith genes for heterologous proteins.
Chiron Viagene Factor VIII WO 96/21035
Emeryville, Calif. retroviral vectors
Retroviral vectors for directing expression of full length Factor VIII,plasmids, host cells, particles.
Chiron Viagene Nucleic acid WO 96/21036
Emeryville, Calif. condensation
Less immunogenic nucleic acid condensing agents generated usingpolycations; for gene delivery.
Ciba Corning Diagnostics Fungi nucleic WO 96/21741
Medfield, Mass. acid probes
Nucleic acid probes and primers specific to various species ofdisease-causing fungi.
Columbia Univ. Prostate tumor WO 96/21671
New York antigens
Genes for prostate tumor antigens, encoded proteins, antibodies; fordiagnosis and therapy.
Dana-Farber Cancer Inst. Cancer- WO 96/21021
Boston associated helicase
Cancer-associated gene for a testis-associated helicase with multiplefunctions, encoded protein.
Human Genome Sciences Deoxycytidine WO 96/21724
Rockville, Md. kinase 2
Gene for human deoxycytidine kinase 2, encoded proteins; fortreating cancer and viral diseases.
Human Genome Sciences Geranylgeranyl WO 96/21736
Rockville, Md. pyrophosphate synthetase
Gene for human geranylgeranyl pyrophosphate synthetase, encodedprotein, antibodies.
Innovir Labs External guide WO 96/21731
New York sequences
Stabilized external guide sequence molecules that cleave specificRNAs using their RNase P activity.
INSERM (Natl. Inst. Adrenoleuko- WO 96/21733
Hlth. Med. Res.) dystrophy vector
Paris
Recombinant vector containing gene associated withadrenoleukodystrophy; for therapy.
Japan Res. Develop. Corp. Oncogene EPO 723 014
Saitama, Japan product ligand
Gene for DOCK180, encoded protein which binds to the proto-oncogene product CRK, antibodies to this protein.
Johns Hopkins Univ. Colorectal WO 96/21026
Baltimore polymerase mutations
Gene for human polymerase gamma, mutations associated withcolorectal cancer; for diagnosis and therapy.
Karo Bio Thyroid hormone WO 96/21728
Huddinge, Sweden receptor defects
Transgenic animals with defective thyroid hormone receptor gene,derived cells; for identifying antagonists.
Keygene Simple sequence EPO 721 987
Wageningen, amplification
the Netherlands
Process for the selective amplification of restriction fragmentscontaining simple sequence repeats.
Leuven Res. & Develop. Less immunogenic EPO 721 982&
Leuven, staphylokinase WO 96/21016
the Netherlands
Gene for staphylokinase derivatives with reduced immunogenicity,site-directed mutated genes, encoded protein.
Leuven Res. & Develop. Steroid-induced EPO 721 984
Leuven, enhancer
the Netherlands
Upstream enhancer element from human tPA gene that is regulatedby steroids or retinoids, expression vector.
Mass. Gen. Hosp. Programmed WO 96/20721
Boston cell death genes
Genes involved in programmed cell death, encoded proteins; for celldeath control.
Mass. Inst. Technol. Composite DNA WO 96/20951
Cambridge, Mass. binders
Chimeric proteins with composite DNA-binding regions, genesencoding these chimeras.
Max Planck Inst. Receptor tyrosine WO 96/21013
Munich, Germany kinase
Gene for MDK1 receptor tyrosine kinase, encoded protein, fortreating signal transduction disorders.
NIH (Natl. Inst. Hlth.) Melanoma antigens WO 96/21734
Bethesda, Md.
Genes for melanoma antigens, encoded antigens, antibodies; fordiagnostic assay.
New Jersey Univ. Med. Dent. Oxidative WO 96/21005
Newark, N.J. species control
Transgenic animals with genes for proteins that control oxidativespecies levels, cells derived from them.
Onyx Pharma Serine protein WO 96/20948
Richmond, Calif. kinase
Gene for the human serine protein kinase PAK65, encoded protein,identification of antagonists.
Otsuka Pharma Cytochrome EPO 723 021
Tokyo P4501A2 polymorphism
Method of detecting human cytochrome P4501A2 genepolymorphism in the untranslated region of the gene.
Planet Biotech Mucosal pathogen WO 96/21012
San Diego protection
Immunoglobulin preparations containing proteins that protect againstmucosal pathogens, production methods.
Procept Soluble T cell WO 96/21028
Cambridge, Mass. receptors
Genes for soluble heterodimeric T cell receptors, encoded proteins,antibodies; for binding assays.
Repligen Angiogenesis EPO 723 015
Cambridge, Mass. inhibition
Conjugate of platelet factor 4 (PF4) or an angiogenesis-inhibitingfragment of PF4 with a second protein.
Rockefeller Univ. First Crk-SH3 WO 96/21011
New York domain ligands
Peptides showing high specificity and affinity for the first SH3domain of cellular Crk; for diagnosis and therapy.
Salk Inst. Farnesol-activated WO 96/21742
La Jolla, Calif. receptor
Nuclear receptor that is activated by farnesol, a cholesterol precursor;for metabolic modulation.
Stryker Osteogenic protein EPO 723 013
Kalamazoo, Mich. devices
Devices containing osteogenic proteins, genes for these proteins; forinducing bone growth.
Suzuki, K. Leukocyte activating EPO 723 016
Chiba-ken, Japan factor
Gene for the leukocyte activating factor LECT2a, encoded protein.
Thomas Jefferson Univ. SV40-based WO 96/20598
Philadelphia gene transduction
Gene transduction system using replication-deficient SV40 virus,production and use methods.
University Technol. Intl. Oil body WO 96/21029
Calgary, Alberta proteins
Genes for oil body proteins, encoded proteins, fusion proteins; forproduction of high value proteins.
Vermont, Univ. of Ribozymes WO 96/21730
Burlington, Vt.
Ribozyme with double-stranded RNA ligand binding site and asingle-stranded loop; for cleavage and ligation.
Virogenetics Poxvirus HTLV WO 96/21727
Troy, N.Y. antigens
Attenuated poxvirus vector containing human T cell lymphotrophicvirus (HTLV) antigens; for diagnosis and therapy.
Yamanouchi Pharma Phospholipase WO 96/20959
Tokyo antibodies
Monoclonal antibodies that inhibit the activity of type IIphospholipase A2; for treating heart attacks and stroke.
Zymogenetics Dimerized EPO 721 983
Seattle proteins
Production of secreted biologically active protein dimers usingfusions with dimerizing proteins.
Zymogenetics Cow Factor XIII WO 96/21025
Seattle
Gene for bovine Factor XIII, encoded protein, host cells, productionmethods; for modifying foodstuff water binding.
_Compiled By Chester A. Bisbee
(c) 1997 American Health Consultants. All rights reserved.